AtriCure, Inc.
ATRCNASDAQHealthcare● Active
$26.92
$-0.19(-0.68%)
Market Cap$1.4B
P/E Ratio—
52W High$43.18
52W Low$25.36
AtriCure, Inc. (ATRC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ATRC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.53B | $0.47B | $0.40B | $0.33B | $0.27B |
| Cost of Revenue | $0.14B | $0.12B | $0.10B | $0.08B | $0.07B |
| Gross Profit | $0.40B | $0.35B | $0.30B | $0.25B | $0.21B |
| Gross Margin %(computed) | 74.41% | 74.69% | 75.23% | 74.44% | 75.04% |
| Operating Expenses | |||||
| R&D Expenses | $0.09B | $0.10B | $0.07B | $0.06B | $0.05B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.40B | $0.39B | $0.33B | $0.29B | $0.15B |
| Operating Income | ($0.00B) | ($0.04B) | ($0.03B) | ($0.04B) | $0.06B |
| Operating Margin %(computed) | -0.64% | -8.60% | -6.68% | -12.92% | 20.12% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.04B) | ($0.03B) | ($0.05B) | $0.05B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.01B) | ($0.04B) | ($0.03B) | ($0.05B) | $0.05B |
| Net Margin %(computed) | -2.14% | -9.61% | -7.62% | -14.06% | 18.30% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.24 | $-0.95 | $-0.66 | $-1.02 | $1.11 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | $0.02B | ($0.02B) | ($0.01B) | ($0.03B) | $0.07B |
| EBITDA Margin %(computed) | 3.04% | -3.98% | -2.03% | -8.93% | 23.97% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more AtriCure, Inc. data
About AtriCure, Inc. (ATRC) Income Statement
AtriCure, Inc. (ATRC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ATRC reported revenue of $0.53B, gross profit of $0.40B (gross margin 74.41%), and net income of ($0.01B) — a net profit margin of -2.14%.
Frequently asked questions
ATRC · 4 questionsAtriCure, Inc. (ATRC) reported revenue of $0.53B for 2025, up 14.9% year-over-year.
ATRC revenueATRC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08